Corruption Conference Speaker Podcasts series, Andrew Bruck discusses the workshop he will be a part of at the event, “The Essent ...

CT-P72/ABP-102 poster selected as one of the Top 150 abstracts out of more than 1,300 submissions at SITC 2025 CT-P72/ABP-102 ...

The AMCP Nexus meeting addressed healthcare policy issues, including PBM reform, Medicaid reform, and the Inflation Reduction Act, with nearly 3,000 attendees. Discussions highlighted the influence of ...

President Donald Trump backed GOP Arkansas Gov. Sarah Huckabee Sanders as well as many House Republicans in Truth Social posts on Sunday ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing ...

CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that ...

The lab where Oppenheimer developed the atomic bomb is the linchpin in the United States’ effort to modernize its nuclear ...

They found that the automated diabetes GLP-1 prior authorization proportion of all diabetes GLP-1 claims grew by 17.5 percentage points, or 39.6%, from October 2024 to July 2025.

Despite the Irish Council for Civil Liberties' complaint, a former colleague writes that the former Facebook/Meta executive could be a powerful asset for the regulator ...

Abpro Corporation and Celltrion announced that they will present new preclinical data for CT-P72/ABP-102, a tetravalent bispecific antibody ...

Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.